Sales & Marketing Sponsored Solution Spotlight: iON.AI iON.AI is a powerful, compliance-driven platform purpose-built for Medical Affairs, seamlessly blending human expertise with AI.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Digital Sponsored The changing landscape of journal performance measurement In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the
Oncology Sponsored 12 Questions with Mimi Huizinga Dr Mimi Huizinga is Vice President, Oncology Medical Affairs, Lung Cancer at AstraZeneca.
R&D Partner Content Returning... The 5th Operationalize Expanded Access Programs... Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
Patients The power of patient insights in shaping successful drug dev... The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like never before.
News Takeda's narcolepsy programme gets back on track Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face